If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLife Settlemen Regulatory News (LSAA)

Share Price Information for Life Settlemen (LSAA)

Share Price is delayed by 15 minutes
Get Live Data
1.795    0.00 (0.00%)
Bid:
1.77
Ask:
1.82
Spread: 0.05 (2.825%)
Market Cap: $74.93m
LSAA Live PriceLast checked at - London Stock Exchange

Intraday Life Settlemen Share Chart

Portfolio Update - Update on MBC finalisation

28 Mar 2025 11:45

RNS Number : 7291C
Life Settlement Assets PLC
28 March 2025
 

This announcement contains inside information

 

Life Settlement Assets PLC (the "Company" or "LSA")

LEI: 2138003OL2VBXWG1BZ27

Update on MBC finalisation

The Company provides an update on the finalisation of the absorption of the MBC portfolio in the Company's asset base.

LSA, the closed end investment trust which manages portfolios of whole interests in life settlement policies issued by life insurance companies, has made steady progress during 2024 on the finalisation of administrative arrangements relating to the MBC action. During 2024 the Company reported that on 28 August 2024 it received notification that funds amounting to USD 9.7 million had been received by the Company, comprising the first tranche of the MBC sale proceeds of USD 5.7 million and the return of overpaid premiums of USD 4.0 million. The impact of this refund was reflected in the 31 July 2024 Net Asset Value of USD 2.33 per share released to the market on 16 September 2024.

The second and final tranche of the MBC sale proceeds of up to USD 6.0 million is expected to be received by the Company during 2025 and has previously been included in the Company's NAV.

However, since the year end further examination of the portfolio acquired from the MBC Trustee by LSA's Investment Manager has revealed that the MBC Trustee had previously not exercised an extension to a particular policy which extended the maturity from 100 to 120 years. This is likely to have a detrimental impact on the NAV of USD 3-4%. A further announcement regarding this will be made in due course.

Michael Baines, Chairman of LSA, said, "This news relating to a previous decision taken by the MBC Trustee is disappointing, and it underlines the correctness of our strategy to take full control of all our policies, removing the dependence on external third parties to maintain the value in our policies. Despite the decision taken by the MBC Trustee, the results of the acquisition have been very favourable for the Company."

 

For further information, please contact:

Acheron Capital Limited (Investment Manager)

Jean-Michel Paul

020 7258 5990

 

Shore Capital (Financial Adviser and Broker)

Gillian Martin / Anita Ghanekar / Harry Davies-Ball

020 7408 4090

 

ISCA Administration Services Limited (the Company Secretary) on

01392 487056; or lsa@iscaadmin.co.uk

 

28 March 2025

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFUJPMBTMTJTBFA
Date   Source Headline
22nd Apr 20227:00 amRNSFinal Results
30th Mar 202210:03 amRNSNet Asset Value(s)
2nd Mar 202211:22 amRNSNet Asset Value(s)
16th Feb 20224:41 pmRNSHolding(s) in Company
19th Jan 20221:05 pmRNSNet Asset Value(s)
21st Dec 202112:08 pmRNSHolding(s) in Company
15th Dec 202110:07 amRNSNet Asset Value(s)
1st Nov 202112:33 pmRNSNet Asset Value(s)
18th Oct 202110:48 amRNSDividend Declaration
15th Oct 202112:22 pmRNSNet Asset Value(s)
27th Sep 20217:00 amRNSHalf-year Report
10th Aug 202111:03 amRNSNet Asset Value(s)
2nd Jul 202112:55 pmRNSDirector/PDMR Shareholding
1st Jul 202111:45 amRNSDirector/PDMR Shareholding
30th Jun 202110:37 amRNSNet Asset Value(s)
16th Jun 20211:52 pmRNSResult of AGM
10th Jun 202111:50 amRNSHolding(s) in Company
3rd Jun 20214:19 pmRNSTotal Voting Rights
3rd Jun 20214:19 pmRNSHolding(s) in Company
2nd Jun 20215:01 pmRNSCapital Reorganisation Following Share Merger
1st Jun 202110:51 amRNSHolding(s) in Company
28th May 20213:17 pmRNSDividend Confirmation
28th May 20212:09 pmRNSNet Asset Value(s)
26th May 20211:02 pmRNSResult of Meeting - General and Share Class
26th May 202112:56 pmRNSHolding(s) in Company
25th May 20217:00 amRNSTimetable Correction
10th May 202112:08 pmRNSNet Asset Value(s)
30th Apr 20217:00 amRNSPublication of circular and notice of GM
30th Apr 20217:00 amRNSAnnual Financial Report
1st Apr 20213:01 pmRNSNet Asset Value(s)
26th Mar 20211:08 pmRNSHolding(s) in Company
4th Mar 202111:53 amRNSNet Asset Value(s)
16th Feb 20211:26 pmRNSNet Asset Value(s)
14th Jan 20213:08 pmRNSNet Asset Value(s)
31st Dec 202011:36 amRNSConfirmation of Directorate Change
22nd Dec 20207:00 amRNSDirectorate Change and new Board structure
4th Dec 20205:55 pmRNSHolding(s) in Company
2nd Dec 20206:05 pmRNSNet Asset Value(s)
2nd Dec 20205:09 pmRNSHolding(s) in Company
4th Nov 20201:10 pmRNSNet Asset Value(s)
29th Oct 20202:07 pmRNSSecond Price Monitoring Extn
29th Oct 20202:01 pmRNSPrice Monitoring Extension
22nd Oct 20204:41 pmRNSSecond Price Monitoring Extn
22nd Oct 20204:36 pmRNSPrice Monitoring Extension
19th Oct 202011:08 amRNSSecond Price Monitoring Extn
19th Oct 202011:01 amRNSPrice Monitoring Extension
7th Oct 20204:48 pmRNSConfirmation of Directorate Change
1st Oct 202012:10 pmRNSNet Asset Value(s)
28th Sep 20207:00 amRNSHalf-year Report
28th Aug 20204:43 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.